1. Home
  2. RYAN vs RGEN Comparison

RYAN vs RGEN Comparison

Compare RYAN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYAN
  • RGEN
  • Stock Information
  • Founded
  • RYAN 2010
  • RGEN 1981
  • Country
  • RYAN United States
  • RGEN United States
  • Employees
  • RYAN N/A
  • RGEN N/A
  • Industry
  • RYAN Specialty Insurers
  • RGEN Medical/Dental Instruments
  • Sector
  • RYAN Finance
  • RGEN Health Care
  • Exchange
  • RYAN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • RYAN 8.5B
  • RGEN 7.6B
  • IPO Year
  • RYAN 2021
  • RGEN N/A
  • Fundamental
  • Price
  • RYAN $64.95
  • RGEN $157.51
  • Analyst Decision
  • RYAN Buy
  • RGEN Buy
  • Analyst Count
  • RYAN 12
  • RGEN 12
  • Target Price
  • RYAN $73.50
  • RGEN $187.44
  • AVG Volume (30 Days)
  • RYAN 798.8K
  • RGEN 511.7K
  • Earning Date
  • RYAN 10-30-2024
  • RGEN 11-12-2024
  • Dividend Yield
  • RYAN 0.67%
  • RGEN N/A
  • EPS Growth
  • RYAN 53.91
  • RGEN N/A
  • EPS
  • RYAN 0.77
  • RGEN N/A
  • Revenue
  • RYAN $2,324,982,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • RYAN $26.22
  • RGEN $2.23
  • Revenue Next Year
  • RYAN $20.37
  • RGEN $10.07
  • P/E Ratio
  • RYAN $84.52
  • RGEN N/A
  • Revenue Growth
  • RYAN 20.14
  • RGEN N/A
  • 52 Week Low
  • RYAN $41.57
  • RGEN $113.50
  • 52 Week High
  • RYAN $75.97
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • RYAN 27.84
  • RGEN 60.44
  • Support Level
  • RYAN $66.83
  • RGEN $151.50
  • Resistance Level
  • RYAN $67.85
  • RGEN $161.24
  • Average True Range (ATR)
  • RYAN 1.48
  • RGEN 5.06
  • MACD
  • RYAN -0.96
  • RGEN 0.89
  • Stochastic Oscillator
  • RYAN 1.67
  • RGEN 82.16

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: